Hansoh Pharmaceutical Group Company Limited: Neoplasms trials

The registry lists 13 Neoplasms studies with Hansoh Pharmaceutical Group Company Limited as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 1 13Phase 2 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of HS-10529 in KRAS G12D Patients With Advanced Solid TumorsNot yet recruitingNCT06963398Phase 1
• Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid TumorsRecruitingNCT06621563Phase 1
• HS-20089 Combination Treatment in Subjects With Advanced Solid TumorsRecruitingNCT06336707Phase 1
• ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid TumorsRecruitingNCT06332170Phase 1
• Study of HS-20105 for Injection in Patients With Advanced Solid Tumors.Not yet recruitingNCT06144723Phase 1/2
• A Phase I Study of HS-10386 in Participants With Advanced Solid TumorsRecruitingNCT05911464Phase 1
• A Study of HS-20089 in Patients With Advanced Solid TumorsRecruitingNCT05263479Phase 1
• Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid TumorsRecruitingNCT05207787Phase 1/2
• A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid TumorsStatus unknownNCT05378178Phase 1
• ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid TumorsStatus unknownNCT05276609Phase 1
• PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid TumorsStatus unknownNCT04477057Phase 1
• A Study of HS-10342 in Patients With Advanced Solid TumorCompletedNCT04060511Phase 1
• A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid TumoursStatus unknownNCT02977364Phase 1